Exelixis Inc
(NAS:EXEL)
$
35.92
0.07 (0.2%)
Market Cap: 10.26 Bil
Enterprise Value: 9.21 Bil
PE Ratio: 23.03
PB Ratio: 4.51
GF Score: 91/100 Exelixis Inc at Cowen HealthCare Conference Transcript
Mar 03, 2020 / 03:00PM GMT
Release Date Price:
$18.74
(-2.85%)
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Okay. Well, welcome once again to the 40th Annual Health Care Conference at Cowen. I'm Yaron Werber, biotech analyst here on the team. And it's a great pleasure to moderate the fireside chat with Mike Morrissey, who is the President and Chief Executive Officer at Exelixis. So Mike, thanks so much for joining.
Michael M. Morrissey
Exelixis, Inc. - CEO, President & Director
Great to be here. Thank you.
Questions & Answers
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Maybe the first question to you is, how many years has it been now for you at Exelixis?
Michael M. Morrissey;Yaron
Exelixis, Inc. - CEO, President & Director
Wow, I just celebrated my 20th anniversary on February 3. So it's like 10 biotech half-lives. So happy I made it so far. So a lot more time to go, for sure.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot